We read with interest the article by Velayutham and colleagues, reporting on shorter regimens for newly diagnosed pulmonary tuberculosis [1]. Shortening duration of treatment is an unmet research need [2]. In this regard, trial et al. commendable. Nevertheless, it has certain limitations. While authors claim that regimen a high cure rate acceptable recurrence rate, we have two main concerns reg...